Datasets:
patient_id string | age_range string | age_midpoint float64 | gender string | ethnicity string | region string | icd10_code string | condition string | severity string | onset_year int64 | medication string | num_visits float64 | adherence_pct float64 | systolic_bp float64 | diastolic_bp float64 | heart_rate float64 | cholesterol_mg_dl float64 | bmi float64 | outcome string | adverse_outcome int64 | gender_enc int64 | ethnicity_enc int64 | region_enc int64 | severity_enc int64 | icd10_code_enc int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P-A476F742 | 30-44 | 52 | Female | Hispanic | Central | M54 | Back Pain | Moderate | 2,010 | Metformin | 8 | 100 | 121 | 74 | 75 | 188 | 27.7 | Recovered | 0 | 0 | 2 | 0 | 1 | 8 |
P-20B3C58F | 30-44 | 37 | Male | White | West | J45 | Asthma | Moderate | 2,021 | Atorvastatin | 6 | 73 | 123 | 76 | 76 | 181 | 30.9 | Stable | 0 | 1 | 4 | 4 | 1 | 6 |
P-BF5527D7 | 0-17 | 8 | Male | Black | Central | K21 | GERD | Severe | 2,023 | Lisinopril | 4 | 46 | 92 | 53 | 78 | 194 | 26.4 | Recovered | 0 | 1 | 1 | 0 | 2 | 7 |
P-18E4D7DD | 75-99 | 87 | Female | White | North | I25 | Coronary Artery Disease | Mild | 2,014 | Lisinopril | 8 | 78 | 189 | 114 | 70 | 247 | 28.9 | Deceased | 1 | 0 | 4 | 2 | 0 | 5 |
P-9D97CFD0 | 60-74 | 67 | Male | White | Central | E11 | Type 2 Diabetes | Severe | 2,018 | Metformin | 10 | 96 | 151 | 98 | 75 | 255 | 33.4 | Deteriorated | 1 | 1 | 4 | 0 | 2 | 1 |
P-6852836F | 75-99 | 87 | Female | White | South | E11 | Type 2 Diabetes | Mild | 2,017 | Metformin | 8 | 77 | 145 | 88 | 78 | 292 | 38.9 | Deteriorated | 1 | 0 | 4 | 3 | 0 | 1 |
P-510FCA3C | 45-59 | 52 | Male | Hispanic | Central | J45 | Asthma | Mild | 2,016 | Sertraline | 2 | 56 | 138 | 78 | 92 | 214 | 30.7 | Deteriorated | 1 | 1 | 2 | 0 | 0 | 6 |
P-B6181CFC | 18-29 | 23 | Non-binary | Hispanic | West | M54 | Back Pain | Moderate | 2,011 | Albuterol | 6 | 100 | 126 | 80 | 77 | 170 | 27.2 | Recovered | 0 | 2 | 2 | 4 | 1 | 8 |
P-4B3159A3 | 45-59 | 52 | Female | White | West | I25 | Coronary Artery Disease | Moderate | 2,020 | Omeprazole | 5 | 57 | 178 | 120 | 79 | 270 | 29.6 | Deceased | 1 | 0 | 4 | 4 | 1 | 5 |
P-3C2A9E41 | 75-99 | 87 | Male | Black | East | N18 | Chronic Kidney Disease | Mild | 2,020 | Lisinopril | 6 | 47 | 174 | 116 | 68 | 211 | 27.3 | Recovered | 0 | 1 | 1 | 1 | 0 | 9 |
P-45864796 | 75-99 | 87 | Female | Hispanic | West | I25 | Coronary Artery Disease | Mild | 2,009 | Lisinopril | 4 | 76 | 183 | 113 | 78 | 223 | 27.3 | Deteriorated | 1 | 0 | 2 | 4 | 0 | 5 |
P-99AF5191 | 30-44 | 52 | Female | White | Central | N18 | Chronic Kidney Disease | Mild | 2,006 | Lisinopril | 6 | 94 | 148 | 85 | 67 | 201 | 22.6 | Stable | 0 | 0 | 4 | 0 | 0 | 9 |
P-3182245F | 75-99 | 52 | Male | White | North | C34 | Lung Cancer | Severe | 2,014 | Omeprazole | 5 | 68 | 149 | 84 | 76 | 235 | 31.3 | Deteriorated | 1 | 1 | 4 | 2 | 2 | 0 |
P-4A4B924A | 45-59 | 52 | Male | Hispanic | North | I25 | Coronary Artery Disease | Mild | 2,007 | Albuterol | 5 | 70 | 159 | 88 | 73 | 251 | 20.1 | Stable | 0 | 1 | 2 | 2 | 0 | 5 |
P-0575DC9F | 45-59 | 52 | Female | Black | South | F32 | Depression | Mild | 2,025 | Lisinopril | 5 | 85 | 131 | 80 | 77 | 218 | 22.3 | Stable | 0 | 0 | 1 | 3 | 0 | 2 |
P-06AE374C | 45-59 | 52 | Female | Hispanic | North | M54 | Back Pain | Mild | 2,017 | Albuterol | 12 | 54 | 144 | 89 | 79 | 223 | 32 | Deteriorated | 1 | 0 | 2 | 2 | 0 | 8 |
P-C156E211 | 45-59 | 52 | Male | Hispanic | South | I25 | Coronary Artery Disease | Mild | 2,015 | Amlodipine | 4 | 73 | 145 | 105 | 68 | 210 | 22.2 | Stable | 0 | 1 | 2 | 3 | 0 | 5 |
P-9E870580 | 30-44 | 37 | Female | White | West | C34 | Lung Cancer | Severe | 2,023 | Omeprazole | 7 | 74 | 134 | 74 | 74 | 171 | 22.3 | Deteriorated | 1 | 0 | 4 | 4 | 2 | 0 |
P-1FDE9954 | 0-17 | 8 | Male | Hispanic | Central | E11 | Type 2 Diabetes | Mild | 2,016 | Amlodipine | 6 | 59 | 120 | 75 | 86 | 219 | 33.6 | Deteriorated | 1 | 1 | 2 | 0 | 0 | 1 |
P-10C2A896 | 18-29 | 23 | Male | White | East | M54 | Back Pain | Mild | 2,025 | Gabapentin | 4 | 89 | 123 | 81 | 75 | 168 | 24.3 | Recovered | 0 | 1 | 4 | 1 | 0 | 8 |
P-AA8D920A | 18-29 | 23 | Male | White | West | I10 | Hypertension | Severe | 2,019 | Gabapentin | 2 | 72 | 141 | 90 | 71 | 192 | 23.9 | Recovered | 0 | 1 | 4 | 4 | 2 | 4 |
P-9C6D1E2E | 75-99 | 87 | Male | White | West | G35 | Multiple Sclerosis | Mild | 2,016 | Sertraline | 8 | 53 | 145 | 104 | 73 | 257 | 29.8 | Deteriorated | 1 | 1 | 4 | 4 | 0 | 3 |
P-50403BFA | 45-59 | 52 | Female | Hispanic | North | I25 | Coronary Artery Disease | Moderate | 2,025 | Metformin | 4 | 74 | 165 | 95 | 76 | 228 | 23.2 | Recovered | 0 | 0 | 2 | 2 | 1 | 5 |
P-76BE7D0A | 45-59 | 52 | Non-binary | White | West | N18 | Chronic Kidney Disease | Moderate | 2,023 | Omeprazole | 4 | 71 | 162 | 100 | 69 | 246 | 26.7 | Deceased | 1 | 2 | 4 | 4 | 1 | 9 |
P-4C218C2A | 45-59 | 52 | Female | White | West | E11 | Type 2 Diabetes | Moderate | 2,019 | Albuterol | 5 | 64 | 132 | 77 | 70 | 232 | 32.4 | Stable | 0 | 0 | 4 | 4 | 1 | 1 |
P-96B4DD89 | 75-99 | 87 | Female | White | Central | J45 | Asthma | Moderate | 2,020 | Omeprazole | 5 | 78 | 150 | 88 | 75 | 211 | 25.3 | Recovered | 0 | 0 | 4 | 0 | 1 | 6 |
P-FA917AD8 | 60-74 | 67 | Female | White | Central | E11 | Type 2 Diabetes | Moderate | 2,025 | Gabapentin | 4 | 85 | 147 | 93 | 64 | 224 | 31.8 | Stable | 0 | 0 | 4 | 0 | 1 | 1 |
P-DC9EAFCE | 75-99 | 87 | Male | White | East | E11 | Type 2 Diabetes | Mild | 2,023 | Amlodipine | 3 | 63 | 182 | 119 | 76 | 268 | 33.4 | Deteriorated | 1 | 1 | 4 | 1 | 0 | 1 |
P-CB171FDA | 75-99 | 87 | Female | White | North | I25 | Coronary Artery Disease | Mild | 2,007 | Omeprazole | 5 | 70 | 167 | 100 | 74 | 202 | 27.8 | Stable | 0 | 0 | 4 | 2 | 0 | 5 |
P-0491082F | 18-29 | 23 | Male | Asian | West | N18 | Chronic Kidney Disease | Mild | 2,024 | Amlodipine | 6 | 75 | 146 | 98 | 72 | 186 | 28.8 | Stable | 0 | 1 | 0 | 4 | 0 | 9 |
P-9ABCFCF0 | 30-44 | 37 | Non-binary | White | East | I10 | Hypertension | Mild | 2,016 | Atorvastatin | 6 | 93 | 159 | 95 | 78 | 218 | 29.2 | Deteriorated | 1 | 2 | 4 | 1 | 0 | 4 |
P-818E3CB4 | 45-59 | 52 | Female | White | South | G35 | Multiple Sclerosis | Mild | 2,022 | Omeprazole | 9 | 74 | 142 | 79 | 69 | 200 | 30.6 | Recovered | 0 | 0 | 4 | 3 | 0 | 3 |
P-73BC2C33 | 45-59 | 52 | Female | Hispanic | East | N18 | Chronic Kidney Disease | Mild | 2,016 | Albuterol | 11 | 98 | 161 | 101 | 75 | 221 | 31.3 | Deteriorated | 1 | 0 | 2 | 1 | 0 | 9 |
P-B752A433 | 60-74 | 67 | Male | White | Central | N18 | Chronic Kidney Disease | Severe | 2,009 | Gabapentin | 5 | 81 | 182 | 107 | 82 | 245 | 30.3 | Deceased | 1 | 1 | 4 | 0 | 2 | 9 |
P-7D0BD159 | 60-74 | 67 | Male | White | North | E11 | Type 2 Diabetes | Mild | 2,015 | Atorvastatin | 14 | 73 | 146 | 94 | 86 | 239 | 33.7 | Deteriorated | 1 | 1 | 4 | 2 | 0 | 1 |
P-1CB14D2E | 0-17 | 8 | Female | Hispanic | North | G35 | Multiple Sclerosis | Moderate | 2,008 | Sertraline | 3 | 74 | 125 | 72 | 74 | 212 | 22.3 | Recovered | 0 | 0 | 2 | 2 | 1 | 3 |
P-FCD986DB | 60-74 | 67 | Female | White | South | M54 | Back Pain | Moderate | 2,023 | Omeprazole | 8 | 84 | 155 | 98 | 78 | 221 | 23.9 | Stable | 0 | 0 | 4 | 3 | 1 | 8 |
P-D348F540 | 60-74 | 67 | Female | White | East | N18 | Chronic Kidney Disease | Mild | 2,022 | Albuterol | 5 | 77 | 163 | 98 | 74 | 197 | 24.9 | Recovered | 0 | 0 | 4 | 1 | 0 | 9 |
P-55E3ABAE | 18-29 | 23 | Male | White | North | N18 | Chronic Kidney Disease | Moderate | 2,016 | Amlodipine | 14 | 52 | 144 | 86 | 75 | 184 | 27.8 | Recovered | 0 | 1 | 4 | 2 | 1 | 9 |
P-22652694 | 60-74 | 67 | Female | Asian | South | J45 | Asthma | Mild | 2,022 | Lisinopril | 7 | 75 | 145 | 89 | 82 | 234 | 30.8 | Stable | 0 | 0 | 0 | 3 | 0 | 6 |
P-58A2DBCA | 75-99 | 87 | Male | White | Central | I25 | Coronary Artery Disease | Moderate | 2,022 | Sertraline | 5 | 68 | 180 | 112 | 75 | 258 | 29.6 | Stable | 0 | 1 | 4 | 0 | 1 | 5 |
P-A1AC460A | 75-99 | 87 | Female | Black | Central | G35 | Multiple Sclerosis | Mild | 2,011 | Omeprazole | 5 | 96 | 152 | 94 | 64 | 210 | 26.9 | Recovered | 0 | 0 | 1 | 0 | 0 | 3 |
P-1EAA4024 | 60-74 | 67 | Female | Asian | Central | N18 | Chronic Kidney Disease | Severe | 2,024 | Metformin | 5 | 78 | 171 | 98 | 67 | 234 | 33 | Deteriorated | 1 | 0 | 0 | 0 | 2 | 9 |
P-0CFE5D36 | 45-59 | 52 | Male | White | South | I10 | Hypertension | Mild | 2,014 | Gabapentin | 2 | 85 | 156 | 95 | 62 | 205 | 27.9 | Recovered | 0 | 1 | 4 | 3 | 0 | 4 |
P-74EC783B | 45-59 | 52 | Male | White | South | C34 | Lung Cancer | Mild | 2,009 | Albuterol | 5 | 59 | 150 | 97 | 83 | 211 | 29.1 | Deteriorated | 1 | 1 | 4 | 3 | 0 | 0 |
P-9FD2AEC5 | 60-74 | 52 | Male | Hispanic | South | I10 | Hypertension | Moderate | 2,016 | Metformin | 4 | 85 | 174 | 117 | 69 | 211 | 27.7 | Deteriorated | 1 | 1 | 2 | 3 | 1 | 4 |
P-4AA2D31B | 0-17 | 8 | Female | Hispanic | North | C34 | Lung Cancer | Moderate | 2,009 | Atorvastatin | 5 | 82 | 113 | 73 | 88 | 214 | 28.2 | Deteriorated | 1 | 0 | 2 | 2 | 1 | 0 |
P-1948500A | 18-29 | 23 | Female | White | East | N18 | Chronic Kidney Disease | Mild | 2,013 | Metformin | 7 | 95 | 158 | 87 | 71 | 203 | 32.3 | Deceased | 1 | 0 | 4 | 1 | 0 | 9 |
P-53EADE03 | 60-74 | 67 | Male | White | South | C34 | Lung Cancer | Severe | 2,012 | Amlodipine | 6 | 57 | 170 | 104 | 75 | 231 | 31.5 | Deceased | 1 | 1 | 4 | 3 | 2 | 0 |
P-D7BAB1A2 | 75-99 | 52 | Male | White | East | C34 | Lung Cancer | Mild | 2,018 | Atorvastatin | 4 | 54 | 150 | 95 | 87 | 237 | 30.9 | Deteriorated | 1 | 1 | 4 | 1 | 0 | 0 |
P-593A8083 | 45-59 | 52 | Male | White | West | E11 | Type 2 Diabetes | Moderate | 2,007 | Lisinopril | 6 | 50 | 123 | 70 | 82 | 229 | 39.8 | Deteriorated | 1 | 1 | 4 | 4 | 1 | 1 |
P-419E2A9D | 45-59 | 52 | Female | White | East | I10 | Hypertension | Mild | 2,023 | Albuterol | 1 | 86 | 161 | 103 | 62 | 208 | 23.1 | Stable | 0 | 0 | 4 | 1 | 0 | 4 |
P-AFDEAF57 | 60-74 | 67 | Male | White | South | C34 | Lung Cancer | Severe | 2,016 | Sertraline | 4 | 72 | 158 | 103 | 71 | 192 | 26.3 | Recovered | 0 | 1 | 4 | 3 | 2 | 0 |
P-F5D7245A | 60-74 | 67 | Female | Other | East | I25 | Coronary Artery Disease | Severe | 2,019 | Gabapentin | 5 | 75 | 169 | 95 | 59 | 214 | 27.8 | Stable | 0 | 0 | 3 | 1 | 2 | 5 |
P-6BE34908 | 45-59 | 52 | Female | White | North | I10 | Hypertension | Moderate | 2,025 | Albuterol | 4 | 51 | 151 | 95 | 81 | 169 | 28 | Stable | 0 | 0 | 4 | 2 | 1 | 4 |
P-468FF01C | 60-74 | 67 | Male | Asian | West | C34 | Lung Cancer | Moderate | 2,012 | Atorvastatin | 4 | 93 | 157 | 88 | 80 | 238 | 27.8 | Deteriorated | 1 | 1 | 0 | 4 | 1 | 0 |
P-03FA05E5 | 45-59 | 52 | Male | White | West | E11 | Type 2 Diabetes | Mild | 2,021 | Amlodipine | 5 | 64 | 133 | 76 | 75 | 224 | 36.9 | Recovered | 0 | 1 | 4 | 4 | 0 | 1 |
P-DDE07C62 | 60-74 | 67 | Female | Asian | South | F32 | Depression | Mild | 2,022 | Omeprazole | 3 | 66 | 145 | 82 | 70 | 195 | 32 | Recovered | 0 | 0 | 0 | 3 | 0 | 2 |
P-9231C3EB | 30-44 | 37 | Male | Black | Central | C34 | Lung Cancer | Mild | 2,021 | Omeprazole | 3 | 86 | 134 | 77 | 75 | 208 | 27.3 | Recovered | 0 | 1 | 1 | 0 | 0 | 0 |
P-64EEAD9F | 30-44 | 37 | Male | Hispanic | West | C34 | Lung Cancer | Moderate | 2,006 | Lisinopril | 9 | 69 | 136 | 75 | 72 | 218 | 29.9 | Deteriorated | 1 | 1 | 2 | 4 | 1 | 0 |
P-819E165C | 30-44 | 37 | Female | Black | Central | N18 | Chronic Kidney Disease | Moderate | 2,014 | Amlodipine | 6 | 74 | 140 | 87 | 82 | 192 | 24.9 | Stable | 0 | 0 | 1 | 0 | 1 | 9 |
P-6FDE9449 | 30-44 | 52 | Female | White | North | K21 | GERD | Severe | 2,023 | Gabapentin | 5 | 91 | 141 | 88 | 70 | 167 | 22.6 | Recovered | 0 | 0 | 4 | 2 | 2 | 7 |
P-631056EB | 30-44 | 37 | Male | White | West | J45 | Asthma | Moderate | 2,019 | Lisinopril | 4 | 86 | 135 | 74 | 66 | 211 | 28 | Recovered | 0 | 1 | 4 | 4 | 1 | 6 |
P-68DB5112 | 45-59 | 52 | Female | Asian | South | I10 | Hypertension | Mild | 2,016 | Omeprazole | 3 | 66 | 153 | 91 | 68 | 211 | 29.1 | Stable | 0 | 0 | 0 | 3 | 0 | 4 |
P-7628DA00 | 60-74 | 67 | Male | White | East | I10 | Hypertension | Moderate | 2,025 | Amlodipine | 8 | 71 | 171 | 102 | 69 | 194 | 26.3 | Stable | 0 | 1 | 4 | 1 | 1 | 4 |
P-ECBEF239 | 60-74 | 67 | Male | Hispanic | North | N18 | Chronic Kidney Disease | Mild | 2,009 | Atorvastatin | 7 | 100 | 165 | 94 | 75 | 187 | 25.7 | Recovered | 0 | 1 | 2 | 2 | 0 | 9 |
P-9D627D8D | 75-99 | 87 | Male | White | North | N18 | Chronic Kidney Disease | Mild | 2,007 | Sertraline | 6 | 82 | 184 | 107 | 85 | 242 | 29.7 | Deteriorated | 1 | 1 | 4 | 2 | 0 | 9 |
P-A952DA5D | 45-59 | 52 | Female | White | East | K21 | GERD | Mild | 2,011 | Atorvastatin | 6 | 86 | 139 | 88 | 59 | 170 | 27.8 | Recovered | 0 | 0 | 4 | 1 | 0 | 7 |
P-99B7575D | 45-59 | 52 | Female | White | West | I25 | Coronary Artery Disease | Mild | 2,022 | Atorvastatin | 9 | 64 | 152 | 85 | 95 | 237 | 30.8 | Deceased | 1 | 0 | 4 | 4 | 0 | 5 |
P-D6C22B9F | 45-59 | 52 | Male | White | Central | N18 | Chronic Kidney Disease | Severe | 2,008 | Gabapentin | 8 | 70 | 155 | 93 | 75 | 202 | 20.7 | Stable | 0 | 1 | 4 | 0 | 2 | 9 |
P-3035C5EF | 45-59 | 52 | Male | White | East | I25 | Coronary Artery Disease | Severe | 2,018 | Sertraline | 5 | 85 | 180 | 116 | 82 | 233 | 28.1 | Deteriorated | 1 | 1 | 4 | 1 | 2 | 5 |
P-83ACB4BF | 75-99 | 87 | Male | White | East | N18 | Chronic Kidney Disease | Mild | 2,022 | Albuterol | 8 | 76 | 194 | 120 | 75 | 227 | 31.1 | Deteriorated | 1 | 1 | 4 | 1 | 0 | 9 |
P-20BEA719 | 18-29 | 23 | Female | Hispanic | West | G35 | Multiple Sclerosis | Moderate | 2,007 | Gabapentin | 7 | 61 | 143 | 82 | 85 | 195 | 27.1 | Deceased | 1 | 0 | 2 | 4 | 1 | 3 |
P-A9F014D0 | 18-29 | 52 | Female | White | North | F32 | Depression | Moderate | 2,018 | Lisinopril | 5 | 92 | 143 | 85 | 76 | 181 | 29.8 | Stable | 0 | 0 | 4 | 2 | 1 | 2 |
P-0972C530 | 45-59 | 52 | Female | Other | West | E11 | Type 2 Diabetes | Severe | 2,010 | Lisinopril | 6 | 59 | 136 | 79 | 67 | 198 | 30 | Stable | 0 | 0 | 3 | 4 | 2 | 1 |
P-007C027B | 30-44 | 37 | Female | White | North | I25 | Coronary Artery Disease | Moderate | 2,018 | Sertraline | 2 | 87 | 157 | 88 | 79 | 254 | 29.5 | Stable | 0 | 0 | 4 | 2 | 1 | 5 |
P-4EDA578F | 60-74 | 67 | Female | White | East | I25 | Coronary Artery Disease | Moderate | 2,010 | Sertraline | 6 | 84 | 148 | 96 | 71 | 219 | 21.3 | Stable | 0 | 0 | 4 | 1 | 1 | 5 |
P-EDA88D7D | 60-74 | 67 | Female | White | South | E11 | Type 2 Diabetes | Mild | 2,012 | Amlodipine | 5 | 56 | 139 | 79 | 72 | 243 | 34.5 | Stable | 0 | 0 | 4 | 3 | 0 | 1 |
P-23D2547A | 45-59 | 52 | Male | Hispanic | West | C34 | Lung Cancer | Severe | 2,009 | Gabapentin | 3 | 64 | 145 | 79 | 88 | 210 | 35.3 | Deteriorated | 1 | 1 | 2 | 4 | 2 | 0 |
P-B90D1E65 | 45-59 | 52 | Female | White | West | N18 | Chronic Kidney Disease | Mild | 2,011 | Albuterol | 7 | 74 | 164 | 102 | 79 | 202 | 23.1 | Deteriorated | 1 | 0 | 4 | 4 | 0 | 9 |
P-223DB4FA | 60-74 | 67 | Female | White | East | J45 | Asthma | Moderate | 2,006 | Amlodipine | 6 | 72 | 142 | 92 | 87 | 199 | 28.7 | Recovered | 0 | 0 | 4 | 1 | 1 | 6 |
P-C4FC3464 | 75-99 | 87 | Female | Hispanic | North | E11 | Type 2 Diabetes | Mild | 2,010 | Amlodipine | 10 | 100 | 143 | 80 | 64 | 255 | 27.6 | Recovered | 0 | 0 | 2 | 2 | 0 | 1 |
P-1B13697A | 60-74 | 67 | Female | White | West | F32 | Depression | Mild | 2,024 | Omeprazole | 5 | 58 | 148 | 97 | 70 | 209 | 27.8 | Stable | 0 | 0 | 4 | 4 | 0 | 2 |
P-7293FBFA | 60-74 | 67 | Male | White | South | I25 | Coronary Artery Disease | Mild | 2,019 | Metformin | 6 | 42 | 176 | 88 | 74 | 264 | 27.5 | Deteriorated | 1 | 1 | 4 | 3 | 0 | 5 |
P-005F55A7 | 60-74 | 67 | Female | Asian | North | E11 | Type 2 Diabetes | Severe | 2,011 | Amlodipine | 10 | 68 | 159 | 88 | 75 | 248 | 30.6 | Deteriorated | 1 | 0 | 0 | 2 | 2 | 1 |
P-1279FAB0 | 60-74 | 67 | Male | White | East | I10 | Hypertension | Mild | 2,008 | Atorvastatin | 5 | 57 | 172 | 95 | 76 | 210 | 24.4 | Stable | 0 | 1 | 4 | 1 | 0 | 4 |
P-3A474808 | 75-99 | 87 | Female | Asian | North | G35 | Multiple Sclerosis | Severe | 2,024 | Lisinopril | 7 | 69 | 177 | 117 | 78 | 240 | 25.1 | Deteriorated | 1 | 0 | 0 | 2 | 2 | 3 |
P-BCF393C8 | 75-99 | 87 | Female | Other | North | K21 | GERD | Mild | 2,025 | Omeprazole | 5 | 71 | 142 | 81 | 76 | 205 | 27.7 | Stable | 0 | 0 | 3 | 2 | 0 | 7 |
P-8EF418B8 | 30-44 | 37 | Male | White | South | C34 | Lung Cancer | Mild | 2,011 | Metformin | 8 | 93 | 129 | 82 | 82 | 205 | 28.8 | Deteriorated | 1 | 1 | 4 | 3 | 0 | 0 |
P-A00F3CA5 | 60-74 | 67 | Non-binary | White | North | G35 | Multiple Sclerosis | Severe | 2,016 | Sertraline | 8 | 68 | 152 | 86 | 73 | 201 | 27.8 | Recovered | 0 | 2 | 4 | 2 | 2 | 3 |
P-2BFD1A84 | 18-29 | 23 | Female | White | South | G35 | Multiple Sclerosis | Mild | 2,008 | Lisinopril | 5 | 63 | 123 | 79 | 78 | 183 | 23.6 | Recovered | 0 | 0 | 4 | 3 | 0 | 3 |
P-E597E9C6 | 60-74 | 67 | Male | Black | East | I10 | Hypertension | Moderate | 2,024 | Gabapentin | 12 | 82 | 180 | 110 | 85 | 212 | 26.7 | Deteriorated | 1 | 1 | 1 | 1 | 1 | 4 |
P-AE5735DC | 60-74 | 67 | Female | Black | Central | I25 | Coronary Artery Disease | Moderate | 2,022 | Atorvastatin | 8 | 67 | 160 | 88 | 84 | 270 | 29.3 | Deteriorated | 1 | 0 | 1 | 0 | 1 | 5 |
P-CE0560B3 | 30-44 | 37 | Female | Hispanic | West | M54 | Back Pain | Severe | 2,010 | Atorvastatin | 6 | 67 | 145 | 80 | 75 | 201 | 17.5 | Stable | 0 | 0 | 2 | 4 | 2 | 8 |
P-B7559794 | 30-44 | 37 | Male | White | South | I25 | Coronary Artery Disease | Mild | 2,024 | Sertraline | 3 | 50 | 139 | 94 | 64 | 228 | 23 | Recovered | 0 | 1 | 4 | 3 | 0 | 5 |
P-6165EBE2 | 45-59 | 52 | Female | White | North | E11 | Type 2 Diabetes | Mild | 2,019 | Metformin | 2 | 92 | 137 | 80 | 79 | 220 | 32.6 | Recovered | 0 | 0 | 4 | 2 | 0 | 1 |
P-5CF5B436 | 45-59 | 52 | Male | White | South | M54 | Back Pain | Mild | 2,021 | Gabapentin | 7 | 75 | 137 | 86 | 70 | 182 | 27.7 | Recovered | 0 | 1 | 4 | 3 | 0 | 8 |
P-8EDD709B | 45-59 | 52 | Male | Other | West | I10 | Hypertension | Moderate | 2,024 | Gabapentin | 5 | 64 | 159 | 93 | 79 | 238 | 26.1 | Recovered | 0 | 1 | 3 | 4 | 1 | 4 |
P-B0AB2D96 | 45-59 | 52 | Male | Asian | Central | N18 | Chronic Kidney Disease | Mild | 2,020 | Gabapentin | 5 | 87 | 160 | 104 | 71 | 211 | 23.6 | Stable | 0 | 1 | 0 | 0 | 0 | 9 |
P-A4DF5232 | 45-59 | 52 | Male | White | East | C34 | Lung Cancer | Moderate | 2,024 | Lisinopril | 3 | 74 | 129 | 86 | 84 | 225 | 24.1 | Recovered | 0 | 1 | 4 | 1 | 1 | 0 |
YAML Metadata Warning:The task_ids "binary-classification" is not in the official list: acceptability-classification, entity-linking-classification, fact-checking, intent-classification, language-identification, multi-class-classification, multi-label-classification, multi-input-text-classification, natural-language-inference, semantic-similarity-classification, sentiment-classification, topic-classification, semantic-similarity-scoring, sentiment-scoring, sentiment-analysis, hate-speech-detection, text-scoring, named-entity-recognition, part-of-speech, parsing, lemmatization, word-sense-disambiguation, coreference-resolution, extractive-qa, open-domain-qa, closed-domain-qa, news-articles-summarization, news-articles-headline-generation, dialogue-modeling, dialogue-generation, conversational, language-modeling, text-simplification, explanation-generation, abstractive-qa, open-domain-abstractive-qa, closed-domain-qa, open-book-qa, closed-book-qa, text2text-generation, slot-filling, masked-language-modeling, keyword-spotting, speaker-identification, audio-intent-classification, audio-emotion-recognition, audio-language-identification, multi-label-image-classification, multi-class-image-classification, face-detection, vehicle-detection, instance-segmentation, semantic-segmentation, panoptic-segmentation, image-captioning, image-inpainting, image-colorization, super-resolution, grasping, task-planning, tabular-multi-class-classification, tabular-multi-label-classification, tabular-single-column-regression, rdf-to-text, multiple-choice-qa, multiple-choice-coreference-resolution, document-retrieval, utterance-retrieval, entity-linking-retrieval, fact-checking-retrieval, univariate-time-series-forecasting, multivariate-time-series-forecasting, visual-question-answering, document-question-answering, pose-estimation
π₯ Synthetic Privacy-Preserving Medical EHR Dataset
Dataset Description
A fully synthetic collection of 10,000 Electronic Health Records (EHRs) for binary classification research. The task is predicting adverse patient outcomes β deterioration or death β from clinical, demographic, and vital sign features. No real patient data was used at any stage. Privacy-safe under GDPR, CCPA, and HIPAA.
Supported Tasks
- tabular-classification: Predict
adverse_outcome(0/1) from 13 clinical features - Benchmark models: Random Forest, Gradient Boosting, XGBoost
- Class imbalance handling: SMOTE oversampling applied on training set only
- Interpretability: SHAP feature importance included in generation pipeline
Dataset Structure
| Split | File | Rows | Strategy |
|---|---|---|---|
| train | train.csv | 7,000 | 70% stratified by target |
| validation | val.csv | 1,500 | 15% stratified by target |
| test | test.csv | 1,500 | 15% stratified by target |
| full | full_dataset.csv | 10,000 | Complete unsplit dataset |
Data Fields
| Field | Type | Description |
|---|---|---|
| patient_id | string | UUID-based anonymous ID (e.g. P-3FA2C1B8) |
| age_range | string | Age bucket: 0-17 / 18-29 / 30-44 / 45-59 / 60-74 / 75-99 |
| age_midpoint | int32 | Midpoint of age bucket β used as numeric ML feature |
| gender | string | Male / Female / Non-binary |
| ethnicity | string | White / Black / Hispanic / Asian / Other |
| region | string | North / South / East / West / Central |
| icd10_code | string | ICD-10 primary diagnosis code |
| condition | string | Hypertension, Diabetes, Cancer, etc. |
| severity | string | Mild / Moderate / Severe |
| onset_year | int32 | Year of diagnosis (2005β2025) |
| medication | string | Primary prescribed medication |
| num_visits | int32 | Number of provider visits |
| adherence_pct | int32 | Treatment adherence percentage 0β100 |
| systolic_bp | int32 | Systolic blood pressure in mmHg |
| diastolic_bp | int32 | Diastolic blood pressure in mmHg |
| heart_rate | int32 | Heart rate in beats per minute |
| cholesterol_mg_dl | int32 | Total cholesterol in mg/dL |
| bmi | float32 | Body Mass Index |
| outcome | string | Recovered / Stable / Deteriorated / Deceased |
| adverse_outcome | int32 TARGET | 1 = Deteriorated or Deceased, 0 = otherwise |
Privacy Methods
This dataset was synthetically generated in Python. Privacy techniques applied:
- Anonymization β UUID patient IDs, no real names or SSNs
- Generalization β age buckets, region labels instead of cities
- Differential Privacy β Laplace mechanism noise (epsilon=2.0) on all vital signs
- Data Perturbation β Gaussian noise on continuous features
No real patient records were used or referenced at any stage.
Benchmark Results
| Model | Val ROC-AUC | Accuracy | F1 Adverse | CV 5-fold |
|---|---|---|---|---|
| Random Forest | 0.9535 | 89% | 0.82 | 0.9707 Β± 0.013 |
| Gradient Boosting | 0.9630 | 90% | 0.84 | 0.9760 Β± 0.013 |
| XGBoost (best) | 0.9665 | 91% | 0.85 | 0.9769 Β± 0.012 |
| XGBoost (test) | 0.9542 | 90% | 0.85 | β |
Use Cases
- Binary classification for healthcare outcome prediction
- Benchmarking tabular ML models without privacy risk
- Teaching SMOTE, scaling, hyperparameter tuning, SHAP
- Fairness analysis across demographic groups
- Differential privacy and privacy-preserving AI research
Citation
@dataset{mdsajjadullah_2025_synthetic_ehr,
author = {Md.Sajjad Ullah},
title = {Synthetic Privacy-Preserving Medical EHR Dataset},
year = {2025},
publisher = {Zenodo},
version = {5.0},
doi = {10.5281/zenodo.18968480},
url = {https://doi.org/10.5281/zenodo.18968480}
}
- Downloads last month
- 26